ClinicalTrials.govpublic full text
AG vs mFOLFIRINOX as Neoadjuvant Therapy for Borderline Reseactable and Locally Advanced Pancreatic Cancer
borderline resectable pancreatic cancer, locally advanced pancreatic adenocarcinoma, neoadjuvant chemotherapy, albumin bound paclitaxel, mfolfirinox, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 882980
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.